CXCL13-CXCR5 signaling in CD8+ T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma.
Saved in:
| Title: | CXCL13-CXCR5 signaling in CD8+ T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma. |
|---|---|
| Authors: | Shapiro DD; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA. DDShapiro@wisc.edu.; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA. DDShapiro@wisc.edu., Nichols KD; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA., Lee MH; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA., Msaouel P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Y; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Zong Y; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Hu R; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Huang W; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Esbona K; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kinoshita T; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Lotan P; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA., Roadman DF; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA., Nkadori E; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., McGregor SM; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Beebe DJ; Department of Pathology and Laboratory Medicine School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA.; Department of Pediatrics School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kerr SC; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA., Capitini CM; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.; Department of Pediatrics School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Abel EJ; Department of Urology School of Medicine and Public Health, University of Wisconsin, 1685 Highland Avenue, Madison, WI, 53705, USA.; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
